Skip to main content
Download PDF

Vitamin D improves the antidiabetic effectiveness of aerobic training via modulation of Akt, PEPCK, and G6Pase expression

Diabetology & Metabolic Syndrome volume 15, Article number: 184 (2023) Cite this article

Abstract

Background

Although the effect of Vitamin D Supplementation (Vit D) on several chronic diseases has been well conceded, its role in diabetes remains ambiguous. The present study investigated the interactive effects of Aerobic Training (AT) and different Vit D doses on Protein Kinase B (Akt), Phosphoenolpyruvate Carboxylase (PEPCK), and Glucose-6-Phosphatase (G6Pase) protein expressions in hepatocytes of type-2 diabetic rats.

Methods

Fifty-six male Wistar rats were divided into 2 groups SHAM (non-diabetic control; n = 8), and diabetic (n = 48). Then, diabetic rats were divided into six groups: AT with high doses of Vit D (D + AT + HD), AT with moderate doses of Vit D (D + AT + MD), high doses of Vit D (D + HD), moderate doses of Vit D (D + MD), AT receiving vehicle (sesame oil; D + AT + oil), and control (oil-receiving). D + AT + HD and D + HD groups received 10,000 IU of Vit D; while D + AT + MD and D + MD groups receive 5000 IU of Vit D once a week by injection; D + AT + oil and SHAM groups received sesame oil. Diabetes was induced via intraperitoneal (IP) injection of streptozotocin (50 mg/kg body weight). After 2 months of intervention, serum insulin, glucose, and visceral fat were measured; protein expressions of Akt, PEPCK, and G6Pase were assessed by western blotting. The paired t-test, one-way analysis of variance (One-Way ANOVA), and the Tukey post hoc test were used at the signification level of P < 0.05.

Results

Our data indicate that the diabeticization of rats increased the level of insulin, glucose, and PEPCK and G6Pase protein expressions and decreased the expression of the Akt (P < 0.05 for all variables). Combined AT and moderate or high Vit D significantly reduced body weight (P = 0.001; P = 0.001), body mass index (P = 0.001; P = 0.002), food intake (P = 0.001; P = 0.001) comparing the pre-test with the post-test, respectively. Also, AT and either high or moderate Vit D alone therapies lead to the improvement of the metabolic state, however, their combination had a more significant effect on the treatment of type 2 diabetes.

Conclusions

Findings from the present study suggested that combined Vit D supplementation and AT successfully improve liver function and attenuate insulin resistance via upregulating Akt and downregulating PEPCK and G6Pase expressions, compared with monotherapy.

Introduction

Type 2 Diabetes mellitus (T2DM) is a chronic metabolic disease and the most common type of diabetes, being primarily identified by increased blood glucose, and insulin resistance [1], with decreased age of onset in recent years, up to 366 million individuals are expected to suffer from T2DM by 2030 [2]. Several lifestyle interventions are used for the management of blood glucose levels in T2DM [3]. Also, increased liver gluconeogenesis has been confirmed as a primary pathological phenomenon, often representing abnormal glucose metabolism in the liver [4].

Glucose-6-Phosphatase (G6Pase) and Phosphoenolpyruvate Carboxylase (PEPCK) are two fundamental liver enzymes converting non‑sugar substances into glucose [4, 5], and their abnormal expression is closely associated with enhanced gluconeogenesis, which is referred as a marker of T2DM [6]. Hepatocyte gluconeogenesis could be regulated under normal insulin signaling by both reducing glucose output and increasing peripheral tissue glucose uptake which is disturbed in T2DM [7, 8]. Therefore, hepatic insulin resistance is a substantial contributor to fasting hyperglycemia in type 2 diabetes [8]. Also, the increased circulating pancreatic insulin inhibits hepatic glucose output via activating the serine/threonine-Protein Kinase B (Akt) during feeding [9]. Based on these studies, PEPCK and G6Pase protein expressions regulate Akt activity [9, 10]. It has been recently reported that PEPCK and G6Pase protein expressions decrease insulin sensitivity via potentiating insulin-mediated suppression of the gluconeogenic program, through Akt phosphorylation [4].

Exercise Training is a major lifestyle therapy in the treatment of type 2 diabetes [11]. Both the acute and persistent effects of Aerobic Training (AT) on glucose disposal and uptake have crucial implications for T2DM patients in terms of transient regulation of glucose homeostasis and chronic metabolic control [12]. Increased activation and/or expression of fundamental proteins that regulate glucose metabolism might be among the molecular mechanisms associated with enhanced insulin following AT [13]. Many studies have demonstrated improved insulin signaling in response to AT in the hepatic tissue [14, 15]; however, the underlying exercise-mediated mechanisms for increased liver insulin sensitivity are not well studied.

Vitamin D (Vit D) supplementation is believed to be linked with gene polymorphism that impairs glucose metabolism [16, 17]. A recent study reported no contribution between extra Vit D supplementation and the prevention of diabetes [18], while some studies suggest that Vit D, as adjuvant therapy, can effectively improve insulin sensitivity and might serve anti‑gluconeogenesis properties in obesity-related diseases [17]. However, limited studies to date have investigated whether the protective mechanism of Vit D on diabetes is associated with hepatocyte gluconeogenesis and the regulation of gluconeogenesis‑related protein expression. Our recent study in elderly women with Vit D deficiency and NAFLD showed significantly reduced anthropometric indices, liver enzymes, and glycemic indices [19]. Hoseini et al. [20] investigated the interactive effect of AT and different doses of Vit D in female Wistar rats introducing AT with high-dose Vit D supplementation as a more favorable method for reducing weight and visceral fat in female Wistar rats with metabolic syndrome.

Therefore, finding interventions with anti‑insulin resistance and anti-gluconeogenic properties to target Akt, PEPCK, and G6Pase may be useful for the treatment of T2DM. Thus, we hypothesized that combination or monotherapy of AT and Vit D might be useful in improving glycemic indices, and the protein expression of Akt, PEPCK, and G6Pase in liver tissue of streptozotocin-induced diabetic rats.

Materials

Animal preparation

In this experimental study, fifty-six 10–12-week male Wistar rats were obtained from the Laboratory Animal Care Center of Medical Sciences University of Kermanshah and then were randomly assigned into two groups; non-diabetic healthy control (SHAM; n = 8) and diabetic (D; n = 48) (Fig. 1). The rats in the diabetic groups (n = 48) were then subdivided into six groups AT with high (D + AT + HD), and moderate (D + AT + MD) Vit D, high (D + HD), and moderate (D + MD) vitamin, AT receiving vehicle (sesame oil; D + AT + oil), and diabetic control (oil-receiving; D + C) groups. In order to determine the sample size, based on previous research, a moderate effect size of 0.5, a power level of 0.8, and a significance level of 0.05, with an estimated standard deviation of 1.5, and seven-group design with an equal allocation ratio was used suggesting a total sample size of 48 rats.

Fig. 1
figure 1

Flow chart of the study. D + AT + HD: diabetic + aerobic training + high dose of vitamin D; D + AT + MD: diabetic + aerobic training + moderate dose of vitamin D; HD: diabetic + high dose of vitamin D; MD: diabetic + moderate dose of vitamin D; D + AT + oil: diabetic + aerobic training + sesame oil; D + C: diabetic + sesame oil; SHAM: non-diabetic control

Full size image

After 2 weeks of adaptation to the new environment, rats in the diabetic groups were fed High-Fat Diet in the form of pellets [HFD; a mixture of standard mouse food powder (365 mg/kg), yeast powder (1 mg/kg), mixed vitamins and minerals (60 mg/kg), sheep fat (310 mg/kg), chloride Sodium (1 mg/kg), and DL-methionine (3 mg/kg) (purchased from Beh-Parvar Company)] to induce obesity for 2 weeks [21, 22]. Diabetes was induced in rats by injecting nicotinamide solution (110 mg/kg body weight) and streptozotocin solution (50 mg/kg body weight) dissolved in citrate buffer (pH = 4.5) after weight increase (above 300 g). Diabetes (glucose levels above 200 mg/dL) was confirmed by measuring tail vein blood using a glucometer (Glucotrend 2, Roche Germany) after 2 weeks [23]. Animals received no insulin treatment throughout the study.

Rats were kept under a 12:12 h dark–light cycle, at a temperature of 21 ± 2 °C, and with a humidity level of 45–55%. They were housed in transparent polycarbonate shelves and provided with standard mouse food and water without any restrictions. All stages of the study were performed following the guidelines of the Ethics Committee of the Razi University of Kermanshah (IR.RAZI.REC.1401.065). All guidelines of laboratory animal studies were considered.

Interventions

Vitamin D supplementation

The vitamin D receptor groups were divided into two protocols for the administration of vitamin D supplements (Table 1). The D + AT + HD and D + HD groups received a high dose of 10,000 IU/kg of vitamin D supplement weekly, while the D + AT + MD and D + MD groups received a moderate dose of 5000 IU/kg of vitamin D supplement weekly. It is worth noting that in both groups, almost 100 IU of vitamin D was derived from food sources. In addition to the oral supplementation, rats also received a weekly injection of vitamin D mixed with sesame oil. This injection served as an additional source of vitamin D, contributing to the overall intake of the participants. The utilization of sesame oil as a carrier for the injection ensured the stability and proper absorption of the vitamin D supplement [24].

Table 1 Numerical representation of the protocol in different weeks
Full size table

Aerobic training

During the experimental sessions, each session began and ended with a 5-min warm-up and cool-down, respectively, at a moderate speed ranging from 5 to 10 m/min [25, 26]. The rats participated in aerobic training (AT) on a treadmill, 5 days a week over a duration of eight weeks. The training regimen commenced with a 15-min session at a speed of 10 m/min, gradually increasing to a 30-min session at a speed of 25 m/min, all performed on a treadmill set at a slope of 0 degrees. It is noteworthy that the running speed served as an indicator of the intensity of the aerobic training, with a range of 20 to 25 m/min considered as an average aerobic activity. This intensity level is estimated to be equivalent to approximately 70–75% of the maximum oxygen consumption [25, 27].

Body weight, body mass index, and food intake

Body weight (using a scale; Sartorius, Germany), Body length (using a tape measure; nose-to-anus), Body Mass Index (BMI), and food intake were recorded weakly between 8 and 10 AM. Food Intake (FI) was measured by subtracting the weight of the uneaten from the total given food [20].

Blood sampling

Forty-eight hours after the last training session, rats were anesthetized via intraperitoneal injection of xylazine (5 mg/kg) and ketamine (50 mg/kg) [28]. After ensuring full anesthesia, blood samples were taken by exposing the vena cava following the dissection of the abdominal cavity. The supernatant, designated as serum, was used to measure glucose, insulin, and serum 25(OH)D concentration after centrifuging the blood samples for 10 min at 4000 g. Serum insulin and glucose concentrations were determined using a rat insulin ELISA kit (DRG, Springfield Township, NJ, USA; intra-assay coefficient of variation = 1.62% and sensitivity of 1.76 mg/dL) and the colorimetric method (GOD-PAP, glucose oxidase aminoantipyrine; Pars Azmoun, Tehran, Iran), respectively. Homeostatic model assessment of insulin resistance (HOMA-IR) was calculated using the following equation [33]:

$$\left( {{\mathbf{fasting}}\;{\mathbf{insulin}}\left[ {{\mathbf{mU}}/{\mathbf{mL}}} \right) \times {\mathbf{fasting}}\;{\mathbf{glucose}}\left[ {{\mathbf{mmol}}/{\mathbf{L}}} \right]/{\mathbf{22}},{\mathbf{5}}} \right)$$

A rat 25(OH)D enzyme-linked immunosorbent assay (ELISA) kit (Immunodiagnostics system Ltd, Boldon, UK) was used to measure serum 25(OH)D concentration with an intraassay coefficient of variation and sensitivity of the method equal to 1.63% and 1.33 mg/dL, respectively.

Liver isolation, immunoprecipitation, and immunoblotting

The hepatic tissue was isolated, minced, and homogenized instantly in extraction buffer (containing 100 sodium fluoride, 100 sodium pyrophosphate, 10 sodium vanadate, 10 EDTA, 0.1 mg of aprotinin/mL, and 2 PMSF; pH 7.4, mM; 1% Triton-X 100, 100 Tris) using a Polytron PTA 20S generator (maximum speed, 48-degree Celsius, 30 s; model PT 10/35; Brinkman Instruments, Westbury, NY). First, the homogenized tissue was centrifuged for 40 min at 11,000 rpm and 48C to remove insoluble material. The tissue supernatants were used for immunoprecipitation (containing 2.0 mg total protein) with antibodies against Akt at 48C overnight, followed by SDS–PAGE, transferred to nitrocellulose membranes, and blotted with PEPCK, and G6Pase antibodies. The immunoblotting experiments were performed by separating the sample protein from150 mg liver protein extracts using SDS–PAGE, transferring to nitrocellulose membranes, and blotting with anti-Akt, anti-PEPCK, and anti-G6Pase (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Protein denaturation was done by boiling in Laemmli buffer in both immunoblotting [100 mM dithiothreitol (DTT)] and immunoprecipitation (50 mM DTT) experiments (Laemmli1970). A chemioluminescence kit was used to label specific bands (Sigma-Aldrich, St Louis, MO). Band intensities were visualized by X-ray film exposure of the membranes and quantified by optical densitometry (Scion Image Software; ScionCorp, Frederick, MD) [29].

Statistical analysis

All data were expressed as mean ± SD. The Shapiro–Wilk was used to check the normality of data distribution, paired t-test analyzed the paired data to analyze paired data of body weight, BMI, and FI and one-way ANOVA followed by a Tukey test was used to compare between groups at significance level P < 0.05 using SPSS version 26.

Results

Table 2 shows the alteration of body weight, BMI, FI, and in both diabetic rats (n = 48) and SHAM (n = 8). Significant differences were observed in body weight, BMI, FI, and between D and SHAM at the beginning and after 8 weeks of intervention. Body weight, BMI, and FI increased significantly in SHAM, while they decreased significantly in the D + AT + HD, D + AT + MD, D + AT + oil, D + HD, and D + MD groups at the end of the study compared with the beginning (P < 0.01) with the highest reduction in D + AT + HD (Table 2).

Table 2 Comparison of mean ± SD of body weight, BMI, FI and WC before and after intervention
Full size table

As Table 3 shows, there was a significant difference in insulin, glucose, HOMA-IR, and serum 25-hydroxyvitamin D between the diabetic and SHAM groups. Furthermore, there were significant differences in insulin, glucose, and HOMA-IR between the diabetic groups, with the lowest level observed in the D + AT + HD group and the highest level observed in the D + C group. The results also indicate a statistically significant difference in serum 25-hydroxyvitamin D between the diabetic groups, except for the D + HD and D + MD groups (P = 0.189). The D + AT + HD group had the highest level of 25-hydroxyvitamin D, while the D + C group had the lowest level (Table 3).

Furthermore, the D + AT + HD, D + AT + MD, D + HD, D + MD, and D + AT + oil groups showed significantly higher levels of serum 25-hydroxyvitamin D compared to the D + C group (P < 0.05 for all three variables) (Table 3).

Table 3 Comparison of mean ± SD of visceral fat, insulin, glucose, HOMA-IR, and vitamin D after the intervention among the groups
Full size table

The results of protein expression of Akt, PEPCK, and G6Pase are shown in Figs. 2, 3, and 4. The protein expression results for Akt, PEPCK, and G6Pase are depicted in Figs. 2, 3, and 4. There were significant differences observed in the protein expression of Akt, PEPCK, and G6Pase between the diabetic groups and the SHAM group. One-way ANOVA analysis also revealed significant differences in the protein expression of Akt, PEPCK, and G6Pase among the diabetic groups. Furthermore, the groups D + AT + HD, D + AT + MD, D + HD, D + MD, and D + AT + oil showed an upregulation of Akt and a downregulation of PEPCK and G6Pase compared to the D + C group (Figs. 2, 3, 4).

Fig. 2
figure 2

Comparison between mean ± SD of AKT protein expression between groups. D + AT + HD: diabetic + aerobic training + high dose of vitamin D; D + AT + MD: diabetic + aerobic training + moderate dose of vitamin D; HD: diabetic + high dose of vitamin D; MD: diabetic + moderate dose of vitamin D; D + AT + oil: diabetic + aerobic training + sesame oil; D + C: diabetic + sesame oil; SHAM: non-diabetic control. Values were calculated using a One-Way analysis of variance followed by post hoc Tukey’s test. The mean values followed by different letters (A, B, C, D, E, F, and G) mean significantly different at the 0.05 level (p < 0.05). The values followed by the same letter are not significantly different. Dissimilar letters represent a significant difference between the groups

Full size image
Fig. 3
figure 3

Comparison between mean ± SD of PEPCK protein expression between groups. D + AT + HD: diabetic + aerobic training + high dose of vitamin D; D + AT + MD: diabetic + aerobic training + moderate dose of vitamin D; HD: diabetic + high dose of vitamin D; MD: diabetic + moderate dose of vitamin D; D + AT + oil: diabetic + aerobic training + sesame oil; D + C: diabetic + sesame oil; SHAM: non-diabetic control. Values were calculated using a One-Way analysis of variance followed by post hoc Tukey’s test. The mean values followed by different letters (A, B, C, D, E, F, and G) mean significantly different at the 0.05 level (p < 0.05). The values followed by the same letter are not significantly different. Dissimilar letters represent a significant difference between the groups

Full size image
Fig. 4
figure 4

Comparison between mean ± SD of G6Pase protein expression between groups. D + AT + HD: diabetic + aerobic training + high dose of vitamin D; D + AT + MD: diabetic + aerobic training + moderate dose of vitamin D; HD: diabetic + high dose of vitamin D; MD: diabetic + moderate dose of vitamin D; D + AT + oil: diabetic + aerobic training + sesame oil; D + C: diabetic + sesame oil; SHAM: non-diabetic control. Values were calculated using a One-Way analysis of variance followed by post hoc Tukey’s test. The mean values followed by different letters (A, B, C, D, E, F, and G) mean significantly different at the 0.05 level (p < 0.05). The values followed by the same letter are not significantly different. Dissimilar letters represent a significant difference between the groups

Full size image

Based on the results, D + AT + HD exhibited a more significant upregulation of Akt (p = 0.024, p = 0.016, p = 0.001, and p = 0.001) and a downregulation of PEPCK (p = 0.029, p = 0.021, p = 0.001, and p = 0.001) and G6Pase (p = 0.019, p = 0.015, p = 0.002, and p = 0.001) compared to D + AT + MD, D + AT + oil, D + HD, and D + MD, respectively. However, the differences between D + AT + MD and D + AT + oil in terms of Akt upregulation and PEPCK and G6Pase downregulation were not statistically significant. Additionally, D + AT + MD induced a more significant upregulation of Akt (p = 0.001 and p = 0.001) and a downregulation of PEPCK (p = 0.001 and p = 0.001) and G6Pase (p = 0.002 and p = 0.001) compared to D + HD and D + MD, respectively.

Moreover, significant differences were observed in the protein expression of Akt, PEPCK, and G6Pase between D + HD and D + MD (P < 0.05 for all three variables).

Discussion

This study investigated the effects of aerobic training and different doses of Vitamin D supplementation on body composition, glycemic control, and protein expression of key gluconeogenic proteins in streptozotocin (STZ)-induced diabetic rats. The results of this trial demonstrated the beneficial effects of an 8-week aerobic training (AT) with high or moderate doses of Vitamin D supplementation on improving body composition, fasting insulin (FI) levels, insulin metabolism, and the expression of Akt, PEPCK, and G6Pase in STZ-induced diabetic rats.

In line with previous studies [30, 31], all diabetic rats showed symptoms of type 2 diabetes mellitus (T2DM) such as weight gain and visceral fat accumulation due to hyperglycemia. However, this study found that 8 weeks of high or moderate Vitamin D supplementation, combined with AT, resulted in significant decreases in body weight, BMI, and FI in rats with T2DM. Importantly, these reductions were more significant when combining Vitamin D with AT compared to separate interventions. This suggests that adequate Vitamin D is crucial to achieving the beneficial effects of AT on weight loss. Consistent with our results, other studies have reported attenuated body weight, BMI, and FI following Vitamin D supplementation [32, 33]. Vitamin D supplementation may alter body weight by improving lipid metabolism through various mechanisms, such as inhibiting parathyroid hormone (PTH) secretion [34], altering lipoprotein lipase activity [35], suppressing the expression of uncoupling proteins in brown adipocytes [36], and affecting resting energy expenditure (REE) in adipose tissue [37], as well as decreasing fatty acid absorption [38].

Additionally, AT has been shown to increase the oxidation of adipose tissue [39, 40] and intramuscular triacylglycerols by increasing the catecholamine response [41, 42] and enhancing the ability of skeletal muscles to use fatty acids through increased adipose tissue and muscle blood flow [42, 43].

Our study found that 8-week 5000 IU/week Vitamin D supplementation significantly decreased insulin resistance in diabetic rats compared to the control (C) group. This finding is consistent with a study by Hoseini et al. [20], which reported that Vitamin D supplementation combined with AT significantly improves dyslipidemia and insulin resistance in ovariectomized rats. Another study by Hoseini et al. [20] suggested that 8-week exercise with 5000 IU/week Vitamin D supplementation reduced insulin levels and HOMA-IR significantly in Vitamin D-deficient women with fatty liver [19]. However, there are also studies with contradictory results [20]. For example, Garg et al. (2015) reported no significant effect on insulin secretion or resistance following 6 months of 4000 IU/day Vitamin D supplementation in Vitamin D-deficient women with polycystic ovary syndrome (PCOS) [44]. Insulin plays a critical role in regulating triglyceride and hepatic glucose production, stimulating glucose uptake in muscles, and inhibiting adipose tissue lipolysis and muscle proteolysis mechanisms. Insulin resistance can disrupt these processes, leading to metabolic complications [45, 46]. Vitamin D may regulate insulin metabolism by stimulating a second messenger system, leading to increased insulin secretion and sensitivity, possibly through increasing calcium influx and intracellular glucose within beta cells, as well as suppressing the release of pro-inflammatory cytokines [47]. Therefore, improved insulin metabolism by Vitamin D supplementation may decrease the risk of metabolic complications related to insulin resistance.

Based on the results of the present study, AT alone significantly decreased insulin resistance in diabetic rats compared to the high-dose (HD), moderate-dose (MD), and control (C) groups. Several molecular pathways could contribute to the decrease in insulin resistance following AT, including the upregulation of insulin-responsive transporters and insulin signal transduction [48, 49]. The activation of the insulin signaling pathway suppresses the gluconeogenic pathways [50], resulting in a rapid fall in hepatic glucose production. Furthermore, AT improves insulin sensitivity by reducing inflammatory cytokines and oxidative stress responses, thus ameliorating the pathophysiologic pathways of insulin resistance [51].

The major finding of this study was the upregulation of hepatic Akt expression, along with the downregulation of PEPCK and G6Pase expression, after the combination of Vitamin D supplementation, AT, and a high dose of Vitamin D compared to the control group. This was accompanied by a decrease in blood glucose concentration. Similar findings of enhanced hepatic insulin signaling and inhibited PEPCK activity have been reported in previous studies following physical exercise in animal models of obesity [52] or T2DM [53, 54].

In accordance with our results, earlier studies indicated an increase in liver Akt mRNA [55], and a decrease in PEPCK, and G6Pase following AT [54, 56]. However, the underlying exercise-mediated mechanisms need to be elucidated, Akt signaling pathway regulates the expression of CREB and FoxO1 which may be associated with the expression of PEPCK and G6Pase [4, 57].

Although, not much is known about the effects of simultaneous Vit D supplementation in mediating AT effects on hepatic metabolic regulators. The results of the present study represent a possibility of the interconnection between Akt, and gluconeogenic protein expressions (PEPCK and G6Pase) with Vit D receptor signaling pathways in the regulation of metabolism. These results suggest that gluconeogenic enzymes are associated with the improvement of hepatic insulin signaling and that exercise and Vit D supplementation are effective therapies for controlling diabetes by targeting hepatocyte gluconeogenesis regulation.

Strengths and limitations

This study’s strength was using a randomized, placebo-controlled, single-blind trial with a low dropout rate, measuring and controlling daily food, and evaluating the protein expression alterations in liver tissue of streptozotocin-induced diabetic rats. There are a few limitations in this study. First, the evaluation of insulin resistance in the current study was only based on HOMA-IR. We did not evaluate the hepatic glucose production, and alterations of transcriptional factors such as TRB3, FoxO1, and PGC-1α signaling in the present study. Second, some of the insignificant results might be related to the short duration of the intervention. So, further studies are required with a longer duration and higher sample size to confirm our findings.

Conclusions

Our data provide evidence that AT and Vit D supplementation improves insulin sensitivity by targeting hepatocyte gluconeogenesis and the regulation of gluconeogenesis‑related protein expression. Taken together, combined treatment with both AT and Vit D has an advantage in controlling diabetes via altering Akt, PEPCK, and G6Pase expression in animal models of T2DM. Further investigations are required to evaluate the effect of exercise on the selective Akt pathway inhibitors and the physiological relevance of this cross-talk.

Availability of data and materials

The datasets generated and analyzed during the current study are not publicly available due to ongoing data analysis but are available from the corresponding author upon reasonable request.

Abbreviations

T2DM:

Type 2 diabetes mellitus

Vit D:

Vitamin D

AT:

Aerobic training

Akt:

Protein Kinase B

PEPCK:

Phosphoenolpyruvate carboxylase

G6Pase:

Glucose-6-phosphatase

UCP2:

Uncoupling protein 2

REE:

Resting energy expenditure

References

  1. Bajinka O, Sylvain Dovi K, Simbilyabo L, Conteh I, Tan Y. The predicted mechanisms and evidence of probiotics on type 2 diabetes mellitus (T2DM). Arch Physiol Biochem. 2023. https://doi.org/10.1080/13813455.2022.2163260.

    Article  PubMed  Google Scholar 

  2. Bhadarge G, Dawande P, Bankar N, Kotecha R. Glycaemic regulation with zinc combination in type 2 diabetes mellitus. J Pharm Res Int. 2021;33(38A):33–7.

    Article  Google Scholar 

  3. Ripsin CM, Kang H, Urban RJ. Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician. 2009;79(1):29–36.

    PubMed  Google Scholar 

  4. Zhu Y-X, Hu H-Q, Zuo M-L, Mao L, Song G-L, Li T-M, Dong L-C, Yang Z-B, Ali Sheikh MS. Effect of oxymatrine on liver gluconeogenesis is associated with the regulation of PEPCK and G6Pase expression and AKT phosphorylation. Biomed Rep. 2021;15(1):1–10.

    Article  Google Scholar 

  5. Barthel A, Schmoll D, Krüger K-D, Bahrenberg G, Walther R, Roth RA, Joost H-G. Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem Biophys Res Commun. 2001;285(4):897–902.

    Article  CAS  PubMed  Google Scholar 

  6. Sharma R, Kumari M, Prakash P, Gupta S, Tiwari S. Phosphoenolpyruvate carboxykinase in urine exosomes reflect impairment in renal gluconeogenesis in early insulin resistance and diabetes. Am J Physiol Renal Physiol. 2020;318(3):F720–31.

    Article  PubMed  Google Scholar 

  7. Jung IR, Anokye-Danso F, Jin S, Ahima RS, Kim SF. IPMK modulates hepatic glucose production and insulin signaling. J Cell Physiol. 2022;237(8):3421–32.

    Article  CAS  PubMed  Google Scholar 

  8. Bu Kang B, Huang Chiang B. A novel phenolic formulation for treating hepatic and peripheral insulin resistance by regulating GLUT4-mediated glucose uptake. J Tradit Complement Med. 2022;12(2):195–205.

    Article  Google Scholar 

  9. Hay N. Akt isoforms and glucose homeostasis—the leptin connection. Trends Endocrinol Metab. 2011;22(2):66–73.

    Article  CAS  PubMed  Google Scholar 

  10. He L, Li Y, Zeng N, Stiles BL. Regulation of basal expression of hepatic PEPCK and G6Pase by AKT2. Biochem J. 2020;477(5):1021–31.

    Article  CAS  PubMed  Google Scholar 

  11. Yang D, Yang Y, Li Y, Han R. Physical exercise as therapy for type 2 diabetes mellitus: from mechanism to orientation. Ann Nutr Metab. 2019;74(4):313–21.

    Article  CAS  PubMed  Google Scholar 

  12. Ferrari F, Bock PM, Motta MT, Helal L. Biochemical and molecular mechanisms of glucose uptake stimulated by physical exercise in insulin resistance state: role of inflammation. Arq Bras Cardiol. 2019;113:1139–48.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Yaribeygi H, Atkin SL, Simental-Mendía LE, Sahebkar A. Molecular mechanisms by which aerobic exercise induces insulin sensitivity. J Cell Physiol. 2019;234(8):12385–92.

    Article  CAS  PubMed  Google Scholar 

  14. Vieira RFL, Muñoz VR, Junqueira RL, de Oliveira F, Gaspar RC, Nakandakari SCBR, Costa SDO, Torsoni MA, da Silva AS, Cintra DE. Time-restricted feeding combined with aerobic exercise training can prevent weight gain and improve metabolic disorders in mice fed a high-fat diet. J Physiol. 2022;600(4):797–813.

    Article  CAS  PubMed  Google Scholar 

  15. Zhang Y, Yang Z, Xu Z, Wan J, Hua T, Sun Q. Exercise ameliorates insulin resistance and improves SIRT6-mediated insulin signaling transduction in liver of obese rats. Can J Physiol Pharmacol. 2021;99(5):506–11.

    Article  CAS  PubMed  Google Scholar 

  16. Vanherwegen A-S, Eelen G, Ferreira GB, Ghesquière B, Cook DP, Nikolic T, Roep B, Carmeliet P, Telang S, Mathieu C. Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabolism. J Steroid Biochem Mol Biol. 2019;187:134–45.

    Article  CAS  PubMed  Google Scholar 

  17. Dong B, Zhou Y, Wang W, Scott J, Kim K, Sun Z, Guo Q, Lu Y, Gonzales NM, Wu H. Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice. Hepatology. 2020;71(5):1559–74.

    Article  CAS  PubMed  Google Scholar 

  18. Pittas AG, Jorde R, Kawahara T, Dawson-Hughes B. Vitamin D supplementation for prevention of type 2 diabetes mellitus: to D or not to D? J Clin Endocrinol Metab. 2020;105(12):3721–33.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hoseini Z, Behpour N, Hoseini R. Co-treatment with vitamin D supplementation and aerobic training in elderly women with Vit D deficiency and NAFLD: a single-blind controlled trial. Hepat Mon. 2020. https://doi.org/10.5812/hepatmon.96437.

    Article  Google Scholar 

  20. Hoseini R, Damirchi A, Babaei P. Vitamin D increases PPARγ expression and promotes beneficial effects of physical activity in metabolic syndrome. Nutrition. 2017;36:54–9.

    Article  CAS  PubMed  Google Scholar 

  21. Mostafavian M, Abdi A, Mehrabani J, Barari A. Effect of eight weeks of aerobic progressive training with capsaicin on changes in PGC-1α and UPC-1 expression in visceral adipose tissue of obese rats with diet. Complement Med J. 2020;10(2):106–17.

    Article  Google Scholar 

  22. Mohammadi K, Khajehlandi A. The effect of a period of swimming training with different temperatures on the expression of β3-AR and ERK2 genes in the visceral adipose tissue of streptozotocin-induced diabetic rats. Feyz J Kashan Univ Med Sci. 2022;25(6):1303–12.

    Google Scholar 

  23. Khalili A, Nekooeian AA, Khosravi MB. Oleuropein improves glucose tolerance and lipid profile in rats with simultaneous renovascular hypertension and type 2 diabetes. J Asian Nat Prod Res. 2017;19(10):1011–21.

    Article  CAS  PubMed  Google Scholar 

  24. Keeney JT, Förster S, Sultana R, Brewer LD, Latimer CS, Cai J, Klein JB, Porter NM, Butterfield DA. Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline. Free Radic Biol Med. 2013;65:324–34.

    Article  CAS  PubMed  Google Scholar 

  25. Dastah S, Tofighi A, Bonab SB. The effect of aerobic exercise on the expression of mir-126 and related target genes in the endothelial tissue of the cardiac muscle of diabetic rats. Microvasc Res. 2021;138: 104212.

    Article  CAS  PubMed  Google Scholar 

  26. Sharma G, Sahu M, Kumar A, Sharma AK, Aeri V, Katare DP. Temporal dynamics of pre and post myocardial infarcted tissue with concomitant preconditioning of aerobic exercise in chronic diabetic rats. Life Sci. 2019;225:79–87.

    Article  CAS  PubMed  Google Scholar 

  27. Høydal MA, Wisløff U, Kemi OJ, Ellingsen Ø. Running speed and maximal oxygen uptake in rats and mice: practical implications for exercise training. Eur J Prev Cardiol. 2007;14(6):753–60.

    Article  Google Scholar 

  28. Marx JO, Jacobsen KO, Petervary NA, Casebolt DB. A survey of laboratory animal veterinarians regarding mouse welfare in biomedical research. J Am Assoc Lab Anim Sci. 2021;60(2):139–45.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Mahmood T, Yang P-C. Western blot: technique, theory, and trouble shooting. N Am J Med Sci. 2012;4(9):429.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Katsuda Y, Ohta T, Miyajima K, Kemmochi Y, Sasase T, Tong B, Shinohara M, Yamada T. Diabetic complications in obese type 2 diabetic rat models. Exp Anim. 2014;63(2):121–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Tang S, Fang C, Liu Y, Tang L, Xu Y. Anti-obesity and anti-diabetic effect of ursolic acid against streptozotocin/high fat induced obese in diabetic rats. J Oleo Sci. 2022;71(2):289–300.

    Article  CAS  PubMed  Google Scholar 

  32. Singh S, Jain R, Singh S. Vitamin D deficiency in patients with diabetes and COVID-19 infection. Diabetes Metab Syndr. 2020;14(5):1033–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Zhang Y, Tan H, Tang J, Li J, Chong W, Hai Y, Feng Y, Lunsford LD, Xu P, Jia D. Effects of vitamin D supplementation on prevention of type 2 diabetes in patients with prediabetes: a systematic review and meta-analysis. Diabetes Care. 2020;43(7):1650–8.

    Article  CAS  PubMed  Google Scholar 

  34. Pokhrel S, Giri N, Pokhrel R, Pardhe BD, Lamichhane A, Chaudhary A, Bhatt MP. Vitamin D deficiency and cardiovascular risk in type 2 diabetes population. Open Life Sci. 2021;16(1):464–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Jahn D, Dorbath D, Schilling A-K, Gildein L, Meier C, Vuille-dit-Bille RN, Schmitt J, Kraus D, Fleet JC, Hermanns HM. Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice. Biochim Biophys Acta (BBA) Mol Basis Dis. 2019;1865(6):1567–78.

    Article  CAS  Google Scholar 

  36. Bhat M, Noolu B, Qadri SS, Ismail A. Vitamin D deficiency decreases adiposity in rats and causes altered expression of uncoupling proteins and steroid receptor coactivator3. J Steroid Biochem Mol Biol. 2014;144:304–12.

    Article  CAS  PubMed  Google Scholar 

  37. Soares MJ, Calton EK, Pathak K, Zhao Y. Hypothesized pathways for the association of vitamin D status and insulin sensitivity with resting energy expenditure: a cross sectional mediation analysis in Australian adults of European ancestry. Eur J Clin Nutr. 2022;76(10):1457–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Singh P, Rawat A, Alwakeel M, Sharif E, Al Khodor S. The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals. Sci Rep. 2020;10(1):1–14.

    Article  Google Scholar 

  39. Lundsgaard A-M, Fritzen AM, Kiens B. Molecular regulation of fatty acid oxidation in skeletal muscle during aerobic exercise. Trends Endocrinol Metab. 2018;29(1):18–30.

    Article  CAS  PubMed  Google Scholar 

  40. Muscella A, Stefàno E, Lunetti P, Capobianco L, Marsigliante S. The regulation of fat metabolism during aerobic exercise. Biomolecules. 2020;10(12):1699.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Arad AD, Basile AJ, Albu J, DiMenna FJ. No influence of overweight/obesity on exercise lipid oxidation: a systematic review. Int J Mol Sci. 2020;21(5):1614.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Rodrigues A, Prímola-Gomes T, Peluzio M, Hermsdorff H, Natali A. Aerobic exercise and lipolysis: a review of the β-adrenergic signaling pathways in adipose tissue. Sci Sports. 2021;36(1):16–26.

    Article  Google Scholar 

  43. Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, George J. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009;50(4):1105–12.

    Article  CAS  PubMed  Google Scholar 

  44. Garg G, Kachhawa G, Ramot R, Khadgawat R, Tandon N, Sreenivas V, Kriplani A, Gupta N. Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study. Endocr Connect. 2015;4(2):108.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Mancusi C, Izzo R, di Gioia G, Losi MA, Barbato E, Morisco C. Insulin resistance the hinge between hypertension and type 2 diabetes. High Blood Press Cardiovasc Prev. 2020;27:515–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Cruz-Pineda WD, Parra-Rojas I, Rodríguez-Ruíz HA, Illades-Aguiar B, Matia-García I, Garibay-Cerdenares OL. The regulatory role of insulin in energy metabolism and leukocyte functions. J Leukoc Biol. 2022;111(1):197–208.

    Article  CAS  PubMed  Google Scholar 

  47. George P, Pearson E, Witham M. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 2012;29(8):e142–50.

    Article  CAS  PubMed  Google Scholar 

  48. Iaccarino G, Franco D, Sorriento D, Strisciuglio T, Barbato E, Morisco C. Modulation of insulin sensitivity by exercise training: implications for cardiovascular prevention. J Cardiovasc Transl Res. 2021;14:256–70.

    Article  PubMed  Google Scholar 

  49. Stocks B, Zierath JR. Post-translational modifications: the signals at the intersection of exercise, glucose uptake, and insulin sensitivity. Endocr Rev. 2022;43(4):654–77.

    Article  PubMed  Google Scholar 

  50. Aji G, Huang Y, Ng ML, Wang W, Lan T, Li M, Li Y, Chen Q, Li R, Yan S. Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2. Proc Natl Acad Sci. 2020;117(39):24434–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Borges YG, Cipriano LHC, Aires R, Zovico PVC, Campos FV, de Araújo MTM, Gouvea SA. Oxidative stress and inflammatory profiles in obstructive sleep apnea: are short-term CPAP or aerobic exercise therapies effective? Sleep Breath. 2020;24:541–9.

    Article  PubMed  Google Scholar 

  52. Heled Y, Shapiro Y, Shani Y, Moran DS, Langzam L, Barash V, Sampson SR, Meyerovitch J. Physical exercise enhances hepatic insulin signaling and inhibits phosphoenolpyruvate carboxykinase activity in diabetes-prone Psammomys obesus. Metabolism. 2004;53(7):836–41.

    Article  CAS  PubMed  Google Scholar 

  53. Zhang Y, Wan J, Xu Z, Hua T, Sun Q. Exercise ameliorates insulin resistance via regulating TGFβ-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats. J Cell Physiol. 2019;234(5):7467–74.

    Article  CAS  PubMed  Google Scholar 

  54. Marinho R, Ropelle ER, Cintra DE, De Souza CT, Da Silva ASR, Bertoli FC, Colantonio E, D’Almeida V, Pauli JR. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss. J Cell Physiol. 2012;227(7):2917–26.

    Article  CAS  PubMed  Google Scholar 

  55. Wu H, Jin M, Han D, Zhou M, Mei X, Guan Y, Liu C. Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway. Biochem Biophys Res Commun. 2015;458(4):862–8.

    Article  CAS  PubMed  Google Scholar 

  56. Shokrolahi Ardakani A, Abednatanzi H, Gholami M, Shakeri N. The effect of resistance training on G6pase gene expression in liver hepatocytes, glucose and insulin resistance levels in type 2 diabetic rats. Iran J Diabetes Obes. 2020;12(1):14–21.

    Google Scholar 

  57. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 2002;13(10):444–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the participants for their cooperation.

Funding

The authors declared that the research did not receive any financial grants.

Author information

Authors and Affiliations

  1. Department of Exercise Physiology, Faculty of Sport Sciences, Razi University, P.O. Box. 6714967346, Kermanshah, Iran

    Zahra Hoseini, Nasser Behpour & Rastegar Hoseini

Authors
  1. Zahra Hoseini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nasser Behpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rastegar Hoseini
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZH and NB were responsible for the study concept and design, the data curation, project administration, and formal analysis, and wrote the original draft. RH contributed to the investigation and the methodology. NB contributed to the resources. All authors wrote, read, and approved the final manuscript draft.

Corresponding author

Correspondence to Nasser Behpour.

Ethics declarations

Ethics approval and consent to participate

All actions performed on the animals were following the guidelines of the Ethics Committee of the Razi University of Kermanshah (IR.RAZI.REC.1401.065 on 21/12/2022), and protocol adheres to the ARRIVE guideline and National Institutes of Health guide for the care and use of laboratory animals.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing financial interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Supplementary Figures.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoseini, Z., Behpour, N. & Hoseini, R. Vitamin D improves the antidiabetic effectiveness of aerobic training via modulation of Akt, PEPCK, and G6Pase expression. Diabetol Metab Syndr 15, 184 (2023). https://doi.org/10.1186/s13098-023-01158-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13098-023-01158-y

Keywords

  • Vitamin D
  • Exercise
  • Insulin resistance
  • Akt
  • PEPCK
  • G6Pas

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us